References
DeLucia MW, Cookson N, Dickson DW (2002) Synuclein-immunoreactive Lewy bodies are detected in the amygdala in less than 20% of Alzheimer's disease (AD) cases. J Neuropathol Exp Neurol 61:454
Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 109:329–339
Jellinger KA (2003) Prevalence of vascular lesions in dementia with Lewy Bodies. A postmortem study. J Neural Transm 110:771–778
Jellinger KA (2003) Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution—a pilot study. Acta Neuropathol 106:DOI 10.1007/s00401-003-0725-y (published online 5 July 2003)
Mikolaenko L, Kwan CH, O'Brien R, Petnikov O, Troncoso JC (2003) Abstracts of the 6th International Conference on AD/PD, Sevilla, Spain, p 133
Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol DOI 10.1007/s00401-003-0750-x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jellinger, K.A. Age-associated prevalence and risk factors of Lewy body pathology in a general population. Acta Neuropathol 106, 383–384 (2003). https://doi.org/10.1007/s00401-003-0751-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-003-0751-9